Comparative genetic and proteomic analysis of late-outgrowth endothelial progenitor cells from pulmonary arterial hypertension patients bearing mutations in bone morphogenetic protein receptor type II

骨形态发生蛋白受体 II 型突变的肺动脉高压患者晚期生长内皮祖细胞的比较遗传和蛋白质组学分析

• 批准号: 203286
• 负责人: Ormiston Mark L
• 金额: $ 10.93万
• 依托单位: University of Cambridge (UK)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-02-01 至 2013-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=203286&lang=en
• 关键词: Bone Morphogenetic Protein 9; Bone Morphogenetic Protein Receptor Type Ii; Endothelial Cells; Endothelial Progenitor Cells; Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a disease that causes a narrowing and loss of the blood vessels in the lung, leading to increased stress on the heart and eventual death by heart failure. There are currently no effective treatments for this devast

肺动脉高压（PAH）是一种导致肺血管狭窄和损失的疾病，导致心脏压力增加，最终因心力衰竭而死亡。目前还没有有效的治疗方法来治疗这种毁灭性的疾病。